Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the rat
Abstract Following a decision to require label warnings for concurrent use of opioids and benzodiazepines and increased risk of respiratory depression and death, the US Food and Drug Administratioin (FDA) recognized that other sedative psychotropic drugs may be substituted for benzodiazepines and be...
Guardado en:
Autores principales: | Lin Xu, Ashok Krishna, Sharron Stewart, Katherine Shea, Rebecca Racz, James L. Weaver, Donna A. Volpe, Nageswara R. Pilli, Suresh Narayanasamy, Jeffry Florian, Vikram Patel, Murali K. Matta, Marc B. Stone, Hao Zhu, Michael C. Davis, David G. Strauss, Rodney Rouse |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/47f7303872624d87ada0be77ae52f79d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An observational cohort study comparing ibuprofen and oxycodone in children with fractures.
por: Samina Ali, et al.
Publicado: (2021) -
Improving Access & Use of Psychotropic Medicines
por: World Health Organization -
PSYCHOTROPIC PROPERTIES OF REMEDY “ADAPTOPHYT-15”
por: M. V. Baldandorzhiyeva, et al.
Publicado: (2012) -
Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone
por: de Biase S, et al.
Publicado: (2016) -
Sedation in the intensive care setting
por: Hughes CG, et al.
Publicado: (2012)